UBS raises IBIT exposure to about 2.5 million shares
UBS reported control of roughly 2.5 million shares of BlackRock’s iShares Bitcoin Trust (IBIT) at the end of June, a position the Swiss bank disclosed in a U.S. Securities and Exchange Commission Form 13F it filed on Aug. 13. The stake was valued at nearly $90 million as of June 30 — an increase in reported value of roughly 230% compared with the end of 2025 — driven largely by UBS adding shares rather than strong IBIT price performance.
Key takeaways
- UBS’s IBIT share count grew from about 549,000 at year-end 2025 to roughly 2.5 million on June 30, a jump of about 355%.
- The June 30 filing reported a position worth nearly $90 million, but a Form 13F does not specify beneficial owners or whether the shares belong to UBS’s own balance sheet or client accounts.
- IBIT’s market-price performance fell sharply in the first half of 2026, so UBS’s increased dollar exposure largely reflects more shares held under its management rather than a rebound in Bitcoin prices.
What the 13F reveals about UBS’s Bitcoin ETF position
UBS’s 13F discloses discretionary positions in U.S.-traded securities at quarter-end for institutional managers with at least $100 million in certain assets under management. The filing lists securities that UBS reported it controlled on June 30, including about 2.5 million IBIT shares. By share count this represents a substantial scaling up of exposure over six months, with UBS adding nearly 2 million IBIT shares during H1 2026.
Measured by reported market value, the position rose from about $27 million at the end of 2025 to close to $90 million on June 30. That gap between share-count growth (355%) and value growth (~230%) stems from IBIT’s price movement: BlackRock’s public fund data shows IBIT’s market-price return declined roughly 32.95% during the first half of 2026, so the higher dollar figure is driven by new purchases rather than a rising IBIT NAV.

Form 13F limitations: ownership, timing and discretion
A 13F is a quarterly snapshot. It reports positions held at the quarter’s close and does not capture trades made between June 30 and the August filing date. Crucially, a 13F does not identify beneficial owners; it aggregates securities managed under the institution’s investment discretion. The reported IBIT shares could be held in UBS proprietary accounts or in client, advisory, wealth-management, or other asset-management mandates.
Consequently, the filing should not be read automatically as a $90 million treasury-level purchase by UBS. It confirms UBS reported control over those IBIT shares for SEC disclosure purposes, but it does not reveal who directed the purchases or the investment objectives behind them.
How UBS is broadening regulated crypto access
Even if the 13F does not specify who owns the shares, UBS has publicly moved to expand digital-asset access for high-net-worth and ultra-high-net-worth clients. In recent months the bank has signaled an intent to allow select private banking clients to gain exposure to Bitcoin via regulated vehicles — notably through U.S.-listed spot Bitcoin ETFs that provide familiar brokerage access without direct crypto custody.
Using exchange-traded products like IBIT enables UBS and eligible clients to obtain price exposure to Bitcoin while avoiding the operational complexity and custody responsibilities of holding on-chain Bitcoin directly. For wealth managers and private banks, ETFs streamline compliance, settlement and reporting by leveraging traditional securities infrastructure.
About BlackRock’s iShares Bitcoin Trust (IBIT)
IBIT trades on Nasdaq and charges a sponsor fee of 0.25%. The trust holds Bitcoin as its sole underlying asset and aims to follow the cryptocurrency’s price. Unlike most mutual funds or ETFs that are registered under the Investment Company Act of 1940, BlackRock notes that IBIT is structured as a trust that is not registered under that Act — a point that means IBIT does not receive every regulatory protection available to conventional investment companies.
As of Aug. 12, BlackRock reported IBIT net assets of about $47.34 billion and roughly 1.32 billion shares outstanding. By that metric, UBS’s reported 2.5 million shares represent approximately 0.19% of the fund’s outstanding share count — a small fraction that would not give UBS control over the product or imply any intention to act as a direct Bitcoin custodian.
U.S. spot Bitcoin ETFs: growing institutional toolset
The SEC’s approval of spot Bitcoin exchange-traded products in January 2024 created a regulated on-ramp for domestic and foreign institutions to obtain Bitcoin exposure through U.S. capital markets. Since then, institutional strategies around these ETFs have diversified: some asset managers have scaled back holdings in one fund while reallocating to others, and banks have used ETF derivatives and options to hedge or express directional views.
A July filing from another major bank illustrated that institutions may trim an IBIT stake while increasing exposure to other token-linked products such as ether or Solana funds. That filing also showed the use of option strategies on IBIT, demonstrating how ETFs can support hedging, market-making, and structured-product overlays in addition to long-only exposure.
Derivatives and liquidity: NYSE Arca options limit increase
Derivative activity tied to IBIT has also expanded. In July the SEC approved an NYSE Arca proposal that raised the options limit on IBIT from 250,000 contracts to 1 million contracts, after the exchange argued higher limits were justified by trading activity. The change aims to help large market participants manage inventory and hedge positions more efficiently without splitting trades because of exchange-imposed ceilings.
Options and other regulated derivatives provide institutional players additional levers to manage risk around IBIT, though BlackRock cautions that the trust’s value will move with Bitcoin and investors can lose principal.
Performance and fund flows in context
IBIT’s performance in H1 2026 was weak: BlackRock’s fund data show a negative net asset value return of approximately 32.97% in the first half, and about a 45.62% decline over the 12 months through June 30. Fund flows have been uneven. On July 30 IBIT attracted $183.4 million — 78.7% of the $233.1 million that entered U.S. spot Bitcoin ETFs that day — as the product group recovered somewhat after substantial outflows earlier in the summer.
At the time, IBIT’s net assets were reported around $47.67 billion while the total U.S. spot Bitcoin ETF complex held about $78.76 billion. Daily trading volumes remain robust — BlackRock cited a 30-day average trading volume near 35.7 million shares — and the fund’s 52-week NAV range has moved widely, reflecting Bitcoin’s volatility and investor rotation among products.
Why this matters for crypto investors and markets
The UBS 13F is notable for several reasons: it shows how large, global financial institutions can access Bitcoin exposure through U.S.-listed securities; it highlights the growing role of ETFs as a regulated interface between traditional finance and crypto; and it underscores that institutional holdings reported in 13Fs may reflect discretionary client allocation rather than a bank’s direct investment.
For investors, the filing illustrates that regulated ETF vehicles can be used for a variety of institutional purposes beyond buy-and-hold, including hedging, liquidity management and structured-product engineering. For the broader market, continued inflows, options expansion and growing product liquidity help reinforce a pipeline of regulated access points to Bitcoin.
What to watch next
- UBS’s next 13F, covering the quarter ended Sept. 30, will disclose whether the bank’s IBIT share count increased, stayed the same, or declined after June 30.
- Monitor IBIT net asset and share-count trends, daily flows, and option open interest for signs of shifting institutional behavior.
- Watch regulatory dynamics around ETF listings, product registrations and derivative limits, which can affect liquidity and trading strategies for Bitcoin-linked ETFs.
Bottom line
UBS’s reported control of roughly 2.5 million IBIT shares valued at nearly $90 million at June 30 signals increased institutional engagement with U.S.-listed spot Bitcoin ETFs. While the 13F confirms UBS managed that exposure at quarter-end, it does not identify whether the shares belong to the bank or to clients. Regardless, the filing reflects the broader trend of major financial institutions integrating regulated Bitcoin products into wealth-management, advisory and trading frameworks — a development that continues to reshape access and risk-management options for crypto investors.
UBS must file its next quarter-end 13F later this year; market participants will be watching whether the bank maintains or adjusts its IBIT allocation amid an evolving ETF landscape and ongoing Bitcoin price volatility.






Discussion
Leave a Comment
Comments (4)
Feels slightly overhyped. UBS owning 0.19% of IBIT isnt control, yet headlines act like a bank takeover. Options limit bump though, interesting move
Pretty balanced take. Good reminder 13Fs are quarter snapshots not proof of a bank treasury buy, would love to see the Sept 30 update tho
Whoa didnt expect them to add that many shares, 355% by count — if real this is a pretty big signal for private banking crypto access, hmm
So UBS shows 2.5M IBIT shares on a 13F but that doc says nothing about who actually owns them? bank, clients, advisors... kinda foggy, anyone got clarity..